不妊治療薬の世界市場（2022年～2028年）

世界の不妊治療薬の市場規模は、予測期間中に約5.1%の大幅なCAGRで成長すると予想されています。市場の成長を後押しする主な要因には、新興国におけるヘルスケア支出の増加、不妊治療に対する意識の高まりなどが挙げられます。

当レポートでは、世界の不妊治療薬市場を調査しており、市場の概要、市場動向の分析、性別タイプ別・治療タイプ別・不妊タイプ別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と見解

• 調査範囲
• アナリストの見解と現在の市場動向

第3章 競合情勢

• 主要企業分析

第4章 市場決定要因

• 促進要因
• 抑制要因
• 機会

第5章 市場セグメンテーション

• 世界の不妊治療薬市場：性別タイプ別
  • 女性不妊治療
  • 男性不妊治療
• 世界の不妊治療薬市場：治療タイプ別
  • ホルモン
  • 体外受精（IVF）
  • 細胞質内精子注入（ICSI）
  • 子宮内授精（IUI）
  • 代替治療・補完治療
• 世界の不妊治療薬市場：不妊タイプ別
  • 排卵の問題
  • 原因不明の不妊症
  • 卵管の閉塞または破損
  • 子宮内膜症
  • 多嚢胞性卵巣症候群

第6章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• その他の地域

第7章 企業プロファイル

• Baxter Healthcare Corp.
• Bayer AG
• Eli Lilly
• Emd Serono Inc.
• F. Hoffmann-La Roche Ltd
• Ferring Pharmaceuticals Inc.
• Johnson & Johnson Pvt. Ltd
• Leadiant Biosciences Inc.
• Merck & Co. Pharmaceutical Co.
• Noven Pharmaceuticalorganon, Inc.
• Pfizer Inc.
• Procter & Gamble Pharmaceuticals
• Solvay
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

• 1. GLOBAL FERTILITY DRUGS MARKET RESEARCH AND ANALYSIS BY GENDER TYPE, 2022-2028 ($ MILLION)
• 2. GLOBAL FEMALE FERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 3. GLOBAL MALE FERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 4. GLOBAL FERTILITY DRUGS MARKET RESEARCH AND ANALYSIS, BY TREATMENT TYPE, 2022-2028($ MILLION)
• 5. GLOBAL HARMONAL FERTILITY DRUGS MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 6. GLOBAL IN-VITRO FERTILIZATION(IVF) MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 7. GLOBAL INTRA CYTOPLASMIC SPERM INJECTION(ICSI) MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 8. GLOBAL INTRA UTERINE INSEMINATION(IUI) MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 9. GLOBAL ALTERNATIVE AND COMPLEMENTRY TREATMENT MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 10. GLOBAL FERTILITY DRUGS MARKET RESEARCH AND ANALYSIS BY INFERTILITY TYPE, 2022-2028 ($ MILLION)
• 11. GLOBAL PROBELEM WITH OVULATING DRUGS MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 12. GLOBAL UNEXPLAINED INFERTILITY DRUGS MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 13. GLOBAL BLOCKED OR DAMAGED TUBES DRUGS MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 14. GLOBAL ENDOMETRIOSIS DRUGS MARKET RESEARCH AND ANALYSIS, 2022-2028 ($ MILLION)
• 15. NORTH AMERICA FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2028 ($ MILLION)
• 16. NORTH AMERICAN FERTILITY DRUGMARKET RESEARCH AND ANALYSIS BY GENDER TYPE, 2022-2028 ($ MILLION)
• 17. NORTH AMERICAN FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2022-2028($ MILLION)
• 18. NORTH AMERICAN FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY INFERTILITY TYPE, 2022-2028($ MILLION)
• 19. EUROPE FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2028($ MILLION)
• 20. EUROPE FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY GENDER TYPE, 2022-2028($ MILLION)
• 21. EUROPE FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2022-2028($ MILLION)
• 22. EUROPE FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY INFERTILITY TYPE, 2022-2028($ MILLION)
• 23. ASIA PACIFIC FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2028($ MILLION)
• 24. ASIA PACIFIC FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY GENDER TYPE, 2022-2028($ MILLION)
• 25. ASIA PACIFIC FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2022-2028($ MILLION)
• 26. ASIA PACIFIC FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY INFERTILITY TYPE, 2022-2028($ MILLION)
• 27. REST OF THE WORLD FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY GENDER TYPE, 2022-2028($ MILLION)
• 28. REST OF THE WORLD FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2022-2028($ MILLION)
• 29. REST OF THE WORLD FERTILITY DRUG MARKET RESEARCH AND ANALYSIS BY INFERTILITY TYPE, 2022-2028($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL FERTILITY DRUG MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL FERTILITY DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL FERTILITY DRUG MARKET, 2021-2028 (%)
• 4. GLOBAL FERTILITY DRUG MARKET SHARE BY GENDER TYPE, 2021 VS 2028 (%)
• 5. GLOBAL FEMALE FERTILITY TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 6. GLOBAL MALE FERTILITY TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 7. GLOBAL FERTILITY DRUG MARKET SHARE BY TREATMENT TYPE, 2021 VS 2028 (%)
• 8. GLOBAL FERTILITY DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 9. GLOBAL IN VITRO FERTILIZATION(IVF) MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 10. GLOBAL INTRA CYTOPLASMIC SPERM INJECTION(ICSI) MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 11. GLOBAL ALTERNATIVE AND COMPLEMENTRY TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 12. GLOBAL FERTILITY DRUG MARKET SHARE BY INFERTILITY TYPE, 2021 VS 2028 (%)
• 13. GLOBAL PROBELEM WITH OVULATING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 14. GLOBAL UNEXPLAINED INFERTILITY DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 15. GLOBAL BLOCKED OR DAMAGED TUBES DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 16. GLOBAL ENDOMETRIOSIS DRUGS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 17. US FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 18. CANADA FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 19. UK FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 20. FRANCE FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 21. GERMANY FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 22. ITALY FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 23. SPAIN FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 24. REST OF EUROPE FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 25. INDIA FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 26. CHINA FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 27. JAPAN FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 28. SOUTH KOREA FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 29. REST OF ASIA-PACIFIC FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)
• 30. REST OF THE WORLD FERTILITY DRUG MARKET SIZE, 2021-2028 ($ MILLION)

Title:Global Fertility Drugs Market Size, Share & Trends Analysis Report by Gender Type (Female Fertility Treatment, Male Fertility Treatment) by Treatment Type (Hormonal, In Vitro Fertilization(IVF), Intra Cytoplasmic Sperm Injection(ICSI), Intrauterine Insemination(IUI), Alternative and Complementary Treatment) by Infertility Type (Problem With Ovulating, Unexplained Infertility, Blocked Or Damaged Tubes, Endometriosis, Polycystic Ovarian Syndrome) Forecast 2022-2028.

The global fertility drugs market is anticipated to grow at a substantial CAGR of around 5.1% during the forecast period. The rising awareness towards the fertility treatment along with increase in healthcare expenditure in emerging economies is propelling the growth of fertility drugs market. The increase in expenditure on healthcare is mainly supported by the need among individuals for quality healthcare services. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 8.63% in 2000 to 9.84% in 2019. Rising healthcare expenditure is allowing a large number of people to access advanced healthcare facilities such as IVF, intra cytoplasmic sperm injection (ICSI), and intrauterine insemination (IUI), which in turn, is contributing to the growth of global fertility drug market.

The global fertility drug market is segmented on the basis on gender type, treatment type and infertility type. Based on gender type, the market is segmented into female fertility treatment, male fertility treatment. The male fertility treatment segment is expected to grow at the fastest rate; the growth is attributed to the increasing incidence of infertility, high adoption of assisted reproductive technology (ART), and technological advancements. According to a report published by National Institute of Health (NHI) in 2019, stated that 8% to 10% of the couples are affected by infertility making it a serious health issue. Based on treatment type, the market is sub-segmented into hormonal, in vitro fertilization (IVF), intra cytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and alternative and complementary treatment. Based on infertility type, the market is sub-segmented into a problem with ovulating, unexplained infertility, blocked or damaged tubes, endometriosis, and polycystic ovarian syndrome.

Geographically market is segmented into: North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific is estimated to contribute significantly to the growth of the market. China and India are the major contributors to the growth of the Asia-Pacific fertility drug market. The major factor that contributes to the growth of the market is the high adoption of costlier treatment, the availability of immense advanced fertility clinics, and the well-established healthcare infrastructure fueling the growth of the global fertility drug market to a large extent.

The major companies serving the global fertility drugs market F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals Inc., Johnson & Johnson Pvt. Ltd., Leadiant Biosciences Inc., and Merck & Co. Pharmaceutical Co., Noven Pharmaceutical organon, Inc., Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2021, Unified Women's Healthcare announced that it has entered into a definitive partnership with CCRM fertility. With this partnership the companies are providing an integrated fertility services platform, helping meet the demand for fertility treatment, and assist serve the patients across the spectrum of women's healthcare.

Research Methodology

The market study of the global fertility drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.

• Whitepapers, research papers, and news blogs.

• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

• Global Fertility Drugs Market Research and Analysis by Gender Type
• Global Fertility Drugs Market Research and Analysis by Treatment Type
• Global Fertility Drugs Market Research and Analysis by Infertility Type

The Report Covers:

• Comprehensive research methodology of the global fertility drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global fertility drugs market.
• Insights about market determinants that are stimulating the global fertility drugs market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Fertility Drug Market
• Recovery Scenario of Global Fertility Drug Market
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight and Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key CompanyAnalysis

4. Market Determinants

• 4.1. Motivators
• 4.2. Restraints
• 4.3. Opportunities

5. Market Segmentation

• 5.1. Global Fertility Drug Market by Gender Type
  • 5.1.1. Female Fertility Treatment
  • 5.1.2. Male Fertility Treatment
• 5.2. Global Fertility Drug Market by Treatment Type
  • 5.2.1. Hormonal
  • 5.2.2. In Vitro Fertilization(IVF)
  • 5.2.3. Intra Cytoplasmic Sperm Injection(ICSI)
  • 5.2.4. Intrauterine Insemination(IUI)
  • 5.2.5. Alternative and Complementary Treatment
• 5.3. Global Fertility Drug Market by Infertility Type
  • 5.3.1. Problem with Ovulating
  • 5.3.2. Unexplained Infertility
  • 5.3.3. Blocked or Damaged Tubes
  • 5.3.4. Endometriosis
  • 5.3.5. Polycystic Ovarian Syndrome

6. Regional Analysis

• 6.1. North America
  • 6.1.1. United States
  • 6.1.2. Canada
• 6.2. Europe
  • 6.2.1. UK
  • 6.2.2. Germany
  • 6.2.3. Italy
  • 6.2.4. Spain
  • 6.2.5. France
  • 6.2.6. Rest of Europe
• 6.3. Asia-Pacific
  • 6.3.1. China
  • 6.3.2. India
  • 6.3.3. Japan
  • 6.3.4. South Korea
  • 6.3.5. Rest of Asia-Pacific
• 6.4. Rest of the World

7. Company Profiles

• 7.1. Baxter Healthcare Corp.
• 7.2. Bayer AG
• 7.3. Eli Lilly
• 7.4. Emd Serono Inc.
• 7.5. F. Hoffmann-La Roche Ltd
• 7.6. Ferring Pharmaceuticals Inc.
• 7.7. Johnson & Johnson Pvt. Ltd
• 7.8. Leadiant Biosciences Inc.
• 7.9. Merck & Co. Pharmaceutical Co.
• 7.10. Noven Pharmaceuticalorganon, Inc.
• 7.11. Pfizer Inc.
• 7.12. Procter & Gamble Pharmaceuticals
• 7.13. Solvay
• 7.14. Takeda Pharmaceutical Co. Ltd.
• 7.15. Teva Pharmaceutical Industries Ltd.